Perdyan, A.; Sobocki, B.K.; Balihodzic, A.; Dąbrowska, A.; Kacperczyk, J.; Rutkowski, J.
The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review. Cancers 2023, 15, 3490.
https://doi.org/10.3390/cancers15133490
AMA Style
Perdyan A, Sobocki BK, Balihodzic A, Dąbrowska A, Kacperczyk J, Rutkowski J.
The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review. Cancers. 2023; 15(13):3490.
https://doi.org/10.3390/cancers15133490
Chicago/Turabian Style
Perdyan, Adrian, Bartosz Kamil Sobocki, Amar Balihodzic, Anna Dąbrowska, Justyna Kacperczyk, and Jacek Rutkowski.
2023. "The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review" Cancers 15, no. 13: 3490.
https://doi.org/10.3390/cancers15133490
APA Style
Perdyan, A., Sobocki, B. K., Balihodzic, A., Dąbrowska, A., Kacperczyk, J., & Rutkowski, J.
(2023). The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review. Cancers, 15(13), 3490.
https://doi.org/10.3390/cancers15133490